吸烟是开颅术后30天死亡的危险因素
基于ACS-NSQIP数据库16280例开颅手术患者,术后30天死亡率为5.03%。以30包年为最佳风险分层阈值,多因素分析显示男性、手术指征和吸烟史≥30包年与30天死亡率相关。分层分析中,吸烟相关死亡风险仅见于男性(OR 2.33,97.5%CI 1.36-4.03),且仅见于因神经血管疾病行开颅术的男性患者(OR 3.88,97.5%CI 1.39-11.65)。
要点
- 开颅术后30天死亡率为5.03%。
- 30包年是预测30天死亡的最佳吸烟阈值。
- 吸烟相关死亡风险仅见于因神经血管疾病手术的男性。
核心结论
- 本研究确定≥30包年是因神经血管疾病行开颅术的男性患者术后30天死亡的危险因素。
研究设计与样本
- 基于ACS-NSQIP数据库识别16280例开颅术后患者,手术指征分为血管、创伤、癫痫、恶性肿瘤和良性肿瘤,采用单因素和多因素logistic回归分析。
主要发现
- 开颅术后30天死亡率为5.03%。
- 多因素分析显示男性(P = 0.002)、手术指征(P < 0.001)和吸烟史≥30包年(P < 0.001)与30天死亡密切相关。
- 分层分析中,吸烟相关死亡风险仅见于男性,≥30包年与<30包年相比OR为2.33(97.5%CI 1.36-4.03)。
- 进一步按手术指征分层,吸烟相关死亡风险仅见于因神经血管疾病行开颅术的男性患者,OR为3.88(97.5%CI 1.39-11.65)。
- 因创伤性脑损伤、恶性肿瘤、良性肿瘤或癫痫行开颅术的患者中未观察到该关联。
关键数值与推荐
- 以30包年作为30天开颅术后死亡风险分层的最佳判别阈值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited information on the impact of smoking on postcraniotomy mortality. In this study we used the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) to examine this issue. METHODS: We identified 16,280 postcraniotomy patients in the ACS-NSQIP database. Indications for surgery were categorized by vascular, trauma, epilepsy, malignant tumor, and benign tumor. Univariate and multivariable logistic regression analyses were used to identify risk factors associated with mortality. RESULTS: In the ACS-NSQIP dataset, postcraniotomy mortality within 30 days of surgery was 5.03%. An area under the curve analysis indicated 30 pack-years as the optimal discriminating threshold for risk stratification in terms of 30-day postcraniotomy mortality. Using this threshold, multivariate analyses revealed 3 variables that were closely associated with 30-day post-craniotomy mortality: male gender (P = 0.002), indication for operation (P < 0.001), and a smoking history of ≥30 pack-years (P < 0.001). In subsequent stratified analyses, smoking-associated mortality risk was observed only in males (odds ratio of 2.33 comparing males with ≥30 and <30 pack-years of smoking history; 97.5% confidence interval 1.36-4.03). When the analysis was further stratified by surgical indications, the mortality association with smoking was found only in male patients who underwent craniotomy as treatment for neurovascular diseases (odds ratio 3.88, 97.5% confidence interval 1.39-11.65). Such an association was not seen in patients who underwent craniotomy for traumatic brain injury, malignant tumors, benign tumors, or epilepsy. CONCLUSIONS: This study identified ≥30 pack-years as a risk factor for male patients undergoing craniotomy as treatment for neurovascular diseases.
引用
- Lochte BC, Carroll KT, Hirshman B, et al. Smoking As a Risk Factor for Postcraniotomy 30-Day Mortality. World Neurosurg. 2019. PMID: 30910752. doi:10.1016/j.wneu.2019.03.138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。